Almac Announce Launch NGS Data Analysis Services
Complete the form below to unlock access to ALL audio articles.
The services are highly customizable and are available on a standalone basis or in combination with Almac's bioinformatics offerings in the areas of biological analysis, biomarker and drug discovery and development and diagnostic product development.
The solutions are delivered through a large and experienced bioinformatics team from a wide range of disciplines including biology, medicine, mathematics and biostatistics. In addition to the team's expertise in bioinformatics and biostatistics they also have substantial experience in molecular and cell biology, drug discovery and development, and diagnostic product development.
Michael Sloan, Vice President of Business Development for Almac said:
"NGS is a rapidly maturing technology that continues to demonstrate significant benefits over traditional methods as well as making substantial steps toward routine use in the clinical setting. By expanding our services to include this range of DNA and RNA-Seq analysis we are empowering our customers with the most cutting edge technologies, opening new avenues within their research and boosting the potential for advancement of human health in a variety of disease settings".
Almac's NGS services build upon long standing expertise in the application of cutting edge technology to the improvement of human health.
